BILLS-116hr6092rfs.pdf

2020 1996 45-day later than 365 days yearly SEPTEMBER 23, 2020 quarterly annually later than 90 days September 22

the ‘‘Veteran’s SESSION H. R. 6092

PO 00000 Frm 00007 PO 00000 Frm 00009 PO 00000 Frm 00004 PO 00000 Frm 00006 PO 00000 Frm 00003 Fmt PO 00000 Frm 00010 PO 00000 Frm 00001 PO 00000 Frm 00008 Fmt PO 00000 Frm 00005 PO 00000 Frm 00002

the United States of America THE UNITED STATES

Congress Department Veterans Affairs the Department of Veterans SEC the National Institute on Minor- Senate National the House of Representatives Veterans Health Administration Medicaid Services Medicare Department medical Health and Health Disparities the Food and Drug Administra- Federal the National Cancer Institute the Committee on Veterans’ Affairs Prostate Cancer Cancer Network Department of Veterans Affairs National Comprehensive House of Representa- the Centers for Disease Control DEVELOPMENT OF NATIONAL CANCER OF THE the Veterans Health Administration Development of the Department of Veterans Academy of Sciences, Engineering Research Institute the National Institutes of Health Institutes and Centers RESEARCH OF PROSTATE CANCER the Department of Defense the Office of Research

CHERYL L. JOHNSON

prostate prostate cancer cancer pathway clinical early detection bills rfs rfs rfs pamtmann comments veterans detection high risk early clinical trials